Therapeutic Uses
Anti-Diabetic
Storage Condition
Store at refrigerator (2-8°C) for long term storage
Synonyms
8-[(3R)-3-Amino-1-piperidinyl]-1-[[4-[[2-[[8-[(3R)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-1-yl]methyl]-1,4-dihydro-4-methyl-4-quinazolinyl]methyl]-2-quinazolinyl]methyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1H-purine-2,6-dione
Application Notes
Useful research chemical for a range of applications
Hazard Compound
No -Refer MSDS for accurate information
Linagliptin Methyldimer is a drug product that is used as an analytical standard for HPLC, as well as in research and development of drugs.
Refund Policy
We are committed to offering products of the highest quality in order to meet the needs of our customers, and have elaborate systems in
place to ensure that material specifications, their certification and all handling and storage conditions are communicated at the time of
material handover.
We have invested in the highest quality packaging materials and use international logistics partners to service our customers. While all
possible precautions have been taken to deliver the required product(s), there may be some rare situations when our product does not
meet your requirements. Should that arise, please contact us with your concerns and we will endeavour to address them on a priority
basis. If there is no other option, we will either replace your product(s) or issue a refund or account credit, whichever you prefer.
If there is an issue with one or more of our products, our policy is that it must be reported to us within 45 days of your receiving shipment.
While we will always address product issues after the 45 day return window has passed, we cannot issue a refund or account credit. As
always, we appreciate your support.
Linagliptin Methyldimer usage and description
Linagliptin dimer impurity is a chemical compound that is related to the diabetes medication, Linagliptin. It is a byproduct that is formed during the manufacturing process of Linagliptin. This impurity is a dimeric form of Linagliptin that is not intended for human consumption.
Linagliptin is an oral medication that is used to treat type 2 diabetes. It is a DPP-4 inhibitor that works by increasing the levels of incretin hormones in the body. These hormones are responsible for increasing insulin production and decreasing glucose production in the liver.
The presence of Linagliptin dimer impurity in Linagliptin medication can affect its effectiveness and safety. Therefore, it is crucial to monitor the levels of this impurity during the manufacturing process and in the final product.
Chemically, Linagliptin dimer impurity is a compound that consists of two Linagliptin molecules joined together by a chemical bond. It has a molecular weight of 1090.23 g/mol and a molecular formula of C50H48N8O8.
In conclusion, Linagliptin dimer impurity is a chemical compound that is formed during the manufacturing of Linagliptin medication. It is not intended for human consumption and can affect the effectiveness and safety of the medication if present in high levels. Therefore, it is essential to monitor its levels during the manufacturing process and in the final product.
